Global Transcriptomics Market

Transcriptomics Market size was valued at USD 5.57 Bn. in 2023 and the total Transcriptomics revenue is expected to grow by 13.56 % from 2024 to 2030, reaching nearly USD 13.57 Bn.

Transcriptomics Market Overview:

Transcriptomics is the study and collection of transcriptomes, and it has a wide range of applications, most notably in molecular genetics. There could be a lot of new product launches in the global transcriptomics industry.

Transcriptomics Market Dynamics:

The growing demand for personalized medicine is the major driving factor for market growth.

In the biotechnology business, there is an increase in the number of PCR applications; this aspect is projected to fuel market growth. The transcriptomics market is predicted to develop due to improvements in the field of transcriptomics, such as the widespread usage of RNA-sequencing and the rise in applications of transcriptomics, such as drug discovery. Furthermore, increased financing and grants from various commercial and government entities have boosted industry growth.

NanoString Technologies, Inc. announced new technologies to evaluate the immune response in COVID-19 disease research in June 2020. To provide a thorough investigation of the viral infection and immune response, the business created the nCounter Host Response Gene Expression Panel and the COVID-19 Panel Plus spike-in. MI Transcriptome, Caris Life Sciences' newest addition to its complete genomic profiling solution, was launched in February 2020, allowing Whole Transcriptome Sequencing (WTS). NuGEN Technologies, Inc.'s Trio RNA-Seq, for example, is well suited for low abundance transcript applications since it provides a very sensitive whole Transcriptomics solution.

However, several RNA sequencing limitations and a scarcity of experienced personnel are projected to limit industry growth. Due to a lack of understanding of concepts and the selection of precise techniques, research and development costs may rise. This can also lengthen the time it takes to complete some studies.
The report has profiled twenty-one key players in the market from different regions. However, the report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for a future hot spot in APAC region.To know about the Research Methodology :- Request Free Sample Report

Transcriptomics Market Segment Analysis:

The Global Transcriptomics Market is segmented on the basis of Technology and Application.

Based on Application, the Diagnostics and Disease Profiling segment is expected to hold a dominant market share during the forecast period. In diagnostics and illness analysis, transcriptomics has a wide range of applications. Transcriptome analyses have been widely used to better understand tumour heterogeneity, classify cancers into molecular subtypes, and identify signals that predict treatment response and patient outcomes. Transcriptomics has transitioned in recent years from pure research uses to diagnostics and medical applications. Transcriptomics are important techniques for speeding up disease diagnosis.

The global burden of chronic diseases such as cancer and diabetes is continuously increasing, necessitating the development of improved illness and diagnostic technologies. According to a report issued by GLOBOCAN 2020, there were around 19.2 million new cancer cases and 9.95 million cancer deaths reported globally. This rapidly growing patient base is likely to have a positive impact on segmental growth. Various transcriptomics market companies are always working on creating and introducing new instruments and techniques in the field of illnesses and diagnostics. For example, Ambry Genetics (Ambry) launched the transcriptomic test +RNAinsight in October 2022.

Transcriptomics Market Regional Insights:

North America is expected to account for significant market share during the forecast period.

North America is predicted to develop the fastest during the forecast period, thanks to increased opportunities, rising healthcare spending, and the implementation of favourable government programmes. North America, particularly the United States, is home to the majority of global manufacturers of transcriptomic systems, platforms, equipment, and technologies. Increased investments in transcriptomics and genomics R&D, as well as increased financing for disease pathology research, have contributed to the company's growth. The growing emphasis on sequencing technologies, the development of more advanced biomedical techniques, and the strong presence of important firms in the region are all likely to boost market revenue growth.

The report also helps in understanding the Global Transcriptomics Market dynamics, structure by analyzing the market segments and project the Global Transcriptomics Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Transcriptomics Market make the report investor’s guide.

Transcriptomics Industry Ecosystem

Transcriptomics Market Scope: Inquire before buying

Transcriptomics Market, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Transcriptomics Market Key Players

1. Becton
2. GE Healthcare
3. Roche Diagnostics
4. Agilent Technologies
5. Thermo Fisher Scientific
6. Illumina, Inc.
7. F. Hoffmann-La Roche Ltd
8. Beckman Coulter, Inc
9. BD
10.Biological Industries
11.bioMérieux SA
12.Bio-Rad Laboratories, Inc
13.Cepheid
14.Takara Bio Inc.
15.Cytognomix
16.Edico Genome
17.Siemens AG
18.QIAGEN
19.Merck KGaA
20.Kapa Biosystems
21.Spatial Transcriptomics

Frequently Asked Questions:

1. Which region has the largest share in the Global Transcriptomics Market?
Ans: In 2023, North America has the largest market share in the global Transcriptomics market.

2. What is the growth rate of the Global Transcriptomics Market?
Ans: The Global Transcriptomics Market is growing at a CAGR of 13.56% during the forecasting period 2024-2030.

3. What is the scope of the Global Transcriptomics market report?
Ans: The Global Transcriptomics Market report helps with the PESTEL, PORTER, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in the Global Transcriptomics market?
Ans: The important key players in the Global Transcriptomics Market are – Becton, GE Healthcare, Roche Diagnostics, Agilent Technologies, Thermo Fisher Scientific, Illumina, Inc., F. Hoffmann-La Roche Ltd, Beckman Coulter, Inc, BD, Biological Industries, bioMérieux SA, Bio-Rad Laboratories, Inc, Cepheid, Takara Bio Inc., Cytognomix, Edico Genome, Siemens AG, QIAGEN, Merck KGaA, Kapa Biosystems, and Spatial Transcriptomics.

5. What is the forecast period of the global transcriptomics market?
Ans: The forecasting period of the Global Transcriptomics Market is from 2024 to 2030.